These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8143369)

  • 41. HER2 codon 655 G-allele is associated with reductions in plasma high-density lipoprotein levels in breast cancer patients treated with tamoxifen.
    Chang NW; Chen DR; Chen FN; Lin C; Wu CT
    J Investig Med; 2011 Dec; 59(8):1252-7. PubMed ID: 21997313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sequential changes in serum triglyceride levels during adjuvant tamoxifen therapy in breast cancer patients and the effect of dose reduction.
    Liu CL; Yang TL
    Breast Cancer Res Treat; 2003 May; 79(1):11-6. PubMed ID: 12779077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women.
    Campos H; McNamara JR; Wilson PW; Ordovas JM; Schaefer EJ
    J Clin Endocrinol Metab; 1988 Jul; 67(1):30-5. PubMed ID: 3379134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects.
    Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JA; Seman LJ; Ferrari A; Rubenstein JJ
    Am J Cardiol; 2002 Oct; 90(7):689-96. PubMed ID: 12356379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects on lipid serum levels of a 2-year adjuvant treatment with exemestane after tamoxifen in postmenopausal women with early breast cancer.
    Montagnani A; Gonnelli S; Cadirni A; Caffarelli C; Del Santo K; Pieropan C; Campagna MS; Montomoli M; Petrioli R; Nuti R
    Eur J Intern Med; 2008 Dec; 19(8):592-7. PubMed ID: 19046724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-dose statin therapy with rosuvastatin reduces small dense LDL and MDA-LDL: The Standard versus high-dose therApy with Rosuvastatin for lipiD lowering (SARD) trial.
    Nishikido T; Oyama J; Keida T; Ohira H; Node K
    J Cardiol; 2016 Apr; 67(4):340-6. PubMed ID: 26162946
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study.
    Wasan KM; Goss PE; Pritchard PH; Shepherd L; Tu D; Ingle JN
    Breast Cancer Res Treat; 2012 Dec; 136(3):769-76. PubMed ID: 23089983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tamoxifen and toremifene lower serum cholesterol by inhibition of delta 8-cholesterol conversion to lathosterol in women with breast cancer.
    Gylling H; Pyrhönen S; Mäntylä E; Mäenpää H; Kangas L; Miettinen TA
    J Clin Oncol; 1995 Dec; 13(12):2900-5. PubMed ID: 8523053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.
    Nicholls SJ; Brewer HB; Kastelein JJ; Krueger KA; Wang MD; Shao M; Hu B; McErlean E; Nissen SE
    JAMA; 2011 Nov; 306(19):2099-109. PubMed ID: 22089718
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors affecting low-density lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West Of Scotland Coronary Prevention Study (WOSCOPS).
    Streja L; Packard CJ; Shepherd J; Cobbe S; Ford I;
    Am J Cardiol; 2002 Oct; 90(7):731-6. PubMed ID: 12356386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A case-control study on the association between serum lipid level and the risk of breast cancer].
    Wei LJ; Zhang C; Zhang H; Wei X; Li SX; Liu JT; Ren XB
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1091-1095. PubMed ID: 28057114
    [No Abstract]   [Full Text] [Related]  

  • 53. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women.
    Furusyo N; Ai M; Okazaki M; Ikezaki H; Ihara T; Hayashi T; Hiramine S; Ura K; Kohzuma T; Schaefer EJ; Hayashi J
    Atherosclerosis; 2013 Dec; 231(2):238-45. PubMed ID: 24267234
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of extended-release niacin on lipoprotein subclass distribution.
    Morgan JM; Capuzzi DM; Baksh RI; Intenzo C; Carey CM; Reese D; Walker K
    Am J Cardiol; 2003 Jun; 91(12):1432-6. PubMed ID: 12804729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
    Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analyzing of high-density lipoprotein subfractions and low-density lipoprotein subfractions in human serum with anion-exchange chromatography.
    Hirowatari Y; Tsunoda Y; Ogura Y; Homma Y
    Atherosclerosis; 2009 Jun; 204(2):e52-7. PubMed ID: 19091316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women.
    Moorjani S; Dupont A; Labrie F; De Lignieres B; Cusan L; Dupont P; Mailloux J; Lupien PJ
    J Clin Endocrinol Metab; 1991 Aug; 73(2):373-9. PubMed ID: 1649840
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LDL-cholesterol lowering or HDL-cholesterol raising for cardiovascular prevention. A lesson from cholesterol turnover studies and others.
    Sirtori CR; Fumagalli R
    Atherosclerosis; 2006 May; 186(1):1-11. PubMed ID: 16310198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.